Avanza Fonder AB Has $893,000 Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Avanza Fonder AB cut its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 43.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,720 shares of the company's stock after selling 2,083 shares during the quarter. Avanza Fonder AB's holdings in Molina Healthcare were worth $893,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rothschild Investment LLC boosted its stake in Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after acquiring an additional 48 shares during the last quarter. Colonial Trust Co SC boosted its stake in Molina Healthcare by 930.0% in the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after acquiring an additional 93 shares during the last quarter. Hurley Capital LLC bought a new position in Molina Healthcare in the fourth quarter valued at approximately $55,000. EverSource Wealth Advisors LLC boosted its stake in Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd boosted its stake in Molina Healthcare by 895.0% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after acquiring an additional 179 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on MOH shares. Guggenheim started coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. Mizuho lifted their price target on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays reduced their price target on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating on the stock in a research report on Monday, June 9th. Finally, Truist Financial lifted their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Nine research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $364.21.

Insiders Place Their Bets

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director now directly owns 11,244 shares in the company, valued at $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Molina Healthcare Stock Down 2.7%

Shares of NYSE:MOH traded down $7.97 during midday trading on Monday, reaching $290.17. 650,832 shares of the company were exchanged, compared to its average volume of 687,699. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a fifty day simple moving average of $315.31 and a two-hundred day simple moving average of $307.29. The firm has a market cap of $15.73 billion, a PE ratio of 14.20, a P/E/G ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period last year, the business posted $5.73 earnings per share. The firm's quarterly revenue was up 12.2% on a year-over-year basis. As a group, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.